Short Interest in BioNexus Gene Lab Corp. (NASDAQ:BGLC) Declines By 50.2%

BioNexus Gene Lab Corp. (NASDAQ:BGLC) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totalling 116,400 shares, a decline of 50.2% from the March 15th total of 233,600 shares. Based on an average daily volume of 85,100 shares, the short-interest ratio is presently 1.4 days. Approximately 6.5% of the company’s stock are short sold.

BioNexus Gene Lab Stock Up 2.2 %

BGLC opened at $2.73 on Friday. BioNexus Gene Lab has a twelve month low of $2.01 and a twelve month high of $10.00. The company has a fifty day simple moving average of $3.10 and a 200 day simple moving average of $3.30.

BioNexus Gene Lab Company Profile

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.